About Tapemark
Tapemark is a Healthcare company based in Saint Paul (United States) founded in 1952, and was acquired by LTS Lohmann in August 2022. CDMO with expertise in transdermal patches and oral transmucosal thin films and catering to pharmaceutical and medical device markets. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Tapemark is a full-service CDMO (contract development and manufacturing organization) providing manufacturing services for drug, device, and combination products. Their capabilities include formulation, blending, coating, converting, packaging, and laboratory services. Drug delivery formats include transdermal drug delivery (claims to be a market leader here), and single-use drug delivery formats such as oral and transmucosal soluble film, topical patches and pads, and Tapemarks patented Snap! and Snapplicator unit-dose packaging for semi-solids. Its labs support Schedule II V Controlled Substances and provide an array of testing services including method development validation, raw material testing, finished product testing and stability services. They also offer microbial limits testing, antimicrobial effectiveness testing, water testing, and environmental monitoring services. Tapemark is cGMP-compliant, and registered with the FDA as a Drug, Device, Food, Cosmetics, and Dietary Supplements contract manufacturer.
- Headquarters Saint Paul, United States
- Stage Acquired
- SectorsHealthcare
- Website tapemark.com
- Social LinkedIn X
- Acquired by LTS Lohmann (Aug 2022)
- Investors
- Acquired byLTS Lohmann
(Aug 2022)
Investors in Tapemark
Tapemark has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LTS Lohmann.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug delivery systems targeting multiple disease indications are developed. | 1997 | ltslohmann.com | Caldwell, United States |
Investor details for Tapemark
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Tapemark
21 people are tracked at Tapemark (4 in leadership, 1 in board & advisors, 16 in team).
| Name | Role | Group |
|---|---|---|
Dave O'Brien | CFO & SVP | Leadership |
Bob Klas | CEO | Leadership |
Jason Heidrich | VP, Operations | Leadership |
Cormac Lyons | VP, Research & Development | Leadership |
Bob Klas, Jr. | Chairman | Board & advisors |
Randy Symanietz | Operations Manager | Team |
Cheryl Shafer | Controller | Team |
Kyle Johnson | Senior Product Development Scientist | Team |
Mary Goblirsch | Planner Scheduler | Team |
Carol Swenson | Front Desk Coordinator | Team |
Lee Frederickson | R&d Process Engineer | Team |
Keir Kristiansen | Research And Development Chemist | Team |
Aric Mathies | R&d Chemist I | Team |
Jim Anderson | Electro/mechanical Tech | Team |
Samantha Tinucci | Research And Development Chemist | Team |
Julie Cardin | Sr. Process Engineer | Team |
Alan Gregory | Production Manager | Team |
Brooke Stewart | Senior Quality Control Manager | Team |
Debra Barrett | Quality Specialist | Team |
Deeann Nelson | Quality Inspector | Team |
1 more people are available in the full profile.
Complete people profiles for Tapemark
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Tapemark
2 dated milestones of Tapemark across 70 years, from founding to its latest funding, stage changes and deals.
- Founded Tapemark is founded.
- Exit Acquired by LTS Lohmann.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Tapemark (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tapemark
Complete news archive for Tapemark
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tapemark
Tapemark was founded in 1952.
Tapemark is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Tapemark is a full-service CDMO (contract development and manufacturing organization) providing manufacturing services for drug, device, and combination products. Their capabilities include formulation, blending, coating, converting, packaging, and laboratory services. Drug delivery formats include transdermal drug delivery (claims to be a market leader here), and single-use drug delivery formats such as oral and transmucosal soluble film, topical patches and pads, and Tapemarks patented Snap! and Snapplicator unit-dose packaging for semi-solids. Its labs support Schedule II V Controlled Substances and provide an array of testing services including method development validation, raw material testing, finished product testing and stability services. They also offer microbial limits testing, antimicrobial effectiveness testing, water testing, and environmental monitoring services. Tapemark is cGMP-compliant, and registered with the FDA as a Drug, Device, Food, Cosmetics, and Dietary Supplements contract manufacturer.
Tapemark has 1 investor. Key investors include LTS Lohmann.
Yes. Tapemark was acquired by LTS Lohmann in August 2022.